Yoshihiro Otani

1.4k total citations · 1 hit paper
65 papers, 853 citations indexed

About

Yoshihiro Otani is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Yoshihiro Otani has authored 65 papers receiving a total of 853 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Genetics, 23 papers in Molecular Biology and 16 papers in Oncology. Recurrent topics in Yoshihiro Otani's work include Glioma Diagnosis and Treatment (29 papers), Virus-based gene therapy research (12 papers) and Meningioma and schwannoma management (8 papers). Yoshihiro Otani is often cited by papers focused on Glioma Diagnosis and Treatment (29 papers), Virus-based gene therapy research (12 papers) and Meningioma and schwannoma management (8 papers). Yoshihiro Otani collaborates with scholars based in Japan, United States and United Kingdom. Yoshihiro Otani's co-authors include Isao Date, Kazuhiko Kurozumi, Tomotsugu Ichikawa, Balveen Kaur, Kyoji Tsuchikama, Wei Xiong, Aiko Yamaguchi, Ningyan Zhang, Zhiqiang An and Yasuaki Anami and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yoshihiro Otani

57 papers receiving 844 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance

2021 210 citations Chisato M. Yamazaki, Aiko Yamaguchi et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yoshihiro Otani Japan	15	373	329	200	186	119	65	853
Jonathan H. Schatz United States	18	614 1.6×	505 1.5×	199 1.0×	92 0.5×	136 1.1×	74	1.5k
Lara Perryman United Kingdom	13	516 1.4×	170 0.5×	327 1.6×	47 0.3×	204 1.7×	19	850
Ali Chahlavi United States	14	253 0.7×	257 0.8×	190 0.9×	67 0.4×	58 0.5×	21	872
Lukas P. Frenzel Germany	19	664 1.8×	354 1.1×	299 1.5×	77 0.4×	225 1.9×	34	1.3k
Alexandra Borodovsky United States	14	698 1.9×	220 0.7×	312 1.6×	34 0.2×	229 1.9×	26	1.0k
Guangzhi Wang China	18	490 1.3×	160 0.5×	118 0.6×	83 0.4×	314 2.6×	49	909
Kruttika Bhat United States	13	393 1.1×	289 0.9×	238 1.2×	60 0.3×	239 2.0×	21	806
Nicole Parker Australia	10	388 1.0×	391 1.2×	239 1.2×	63 0.3×	276 2.3×	16	1.1k
Liutao Du United States	16	832 2.2×	147 0.4×	83 0.4×	140 0.8×	316 2.7×	22	1.1k
Takamitsu Oku United States	8	411 1.1×	158 0.5×	134 0.7×	298 1.6×	152 1.3×	9	916

Countries citing papers authored by Yoshihiro Otani

Since Specialization

Citations

This map shows the geographic impact of Yoshihiro Otani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshihiro Otani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshihiro Otani more than expected).

Fields of papers citing papers by Yoshihiro Otani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshihiro Otani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshihiro Otani. The network helps show where Yoshihiro Otani may publish in the future.

Co-authorship network of co-authors of Yoshihiro Otani

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshihiro Otani. A scholar is included among the top collaborators of Yoshihiro Otani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshihiro Otani. Yoshihiro Otani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Demachi‐Okamura, Ayako, Daisuke Muraoka, Eiichi Sasaki, et al.. (2025). Immune prognostic model for glioblastoma based on the ssGSEA enrichment score. Cancer Genetics. 294-295. 32–41.

Magari, Masaki, Youki Ueda, Takamasa Ishino, et al.. (2025). Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy. Cancer Research. 85(6). 1082–1096. 2 indexed citations

Otani, Yoshihiro, Susumu Sasada, Joji Ishida, et al.. (2025). A Case of Spinal Astroblastoma‐Like Neuroepithelial Tumor With MAMLD1 :: BEND2 Fusion. Pathology International. 76(1). e70075–e70075.

Otani, Yoshihiro, Kana Washio, Shinichiro Koizumi, et al.. (2024). Midline invasion predicts poor prognosis in diffuse hemispheric glioma, H3 G34-mutant: an individual participant data review. Journal of Neuro-Oncology. 167(1). 201–210. 2 indexed citations

Kobayashi, Hiroki, Ryota Chijimatsu, Yoshihiro Otani, et al.. (2024). Single-cell and spatial characterization of plasmablast-like lymphoma cells in primary central nervous system lymphoma. SHILAP Revista de lepidopterología. 2(1). 100058–100058. 2 indexed citations

Otani, Yoshihiro, Kentaro Fujii, Joji Ishida, et al.. (2024). Comparative analysis of intraoperative MRI and early postoperative MRI findings in glioma surgery patients. Journal of neurosurgery. 142(5). 1–9. 2 indexed citations

Zhu, Li, Joji Nagasaki, Yoshihiro Otani, et al.. (2023). Combination therapy with hydrogen peroxide and irradiation promotes an abscopal effect in mouse models. Cancer Science. 114(10). 3848–3856. 6 indexed citations

Otani, Yoshihiro, Kentaro Fujii, Joji Ishida, et al.. (2023). Utility of Comprehensive Genomic Profiling for Precise Diagnosis of Pediatric-Type Diffuse High-Grade Glioma.. PubMed. 77(3). 323–330. 2 indexed citations

Kurozumi, Kazuhiko, Yoshihiro Otani, Atsuhito Uneda, et al.. (2022). Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasion and angiogenesis. PLoS ONE. 17(8). e0273242–e0273242. 3 indexed citations

10.

Horikawa, Makoto, Shinichiro Koizumi, Masashi Ikeno, et al.. (2022). Potent bystander effect and tumor tropism in suicide gene therapy using stem cells from human exfoliated deciduous teeth. Cancer Gene Therapy. 30(1). 85–95. 3 indexed citations

11.

Kurozumi, Kazuhiko, Kentaro Fujii, Kana Washio, et al.. (2022). Response to entrectinib in a malignant glioneuronal tumor with ARHGEF2-NTRK fusion. Neuro-Oncology Advances. 4(1). vdac094–vdac094. 3 indexed citations

12.

Rogers, William, Guy R. Simpson, Carla S. Möller‐Levet, et al.. (2022). HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiforme. BMC Cancer. 22(1). 400–400. 12 indexed citations

13.

Yamazaki, Chisato M., Aiko Yamaguchi, Yasuaki Anami, et al.. (2021). Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance. Nature Communications. 12(1). 3528–3528. 210 indexed citations breakdown →

14.

Yoo, Ji Young, Yoshihiro Otani, Jin Muk Kang, et al.. (2021). MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44. Scientific Reports. 11(1). 9219–9219. 31 indexed citations

15.

Otani, Yoshihiro, Toshihiko Shimizu, Jin Muk Kang, et al.. (2020). Enhancing Antitumor Efficacy of Heavily Vascularized Tumors by RAMBO Virus through Decreased Tumor Endothelial Cell Activation. Cancers. 12(4). 1040–1040. 14 indexed citations

16.

Tomita, Yusuke, Kazuhiko Kurozumi, Ji Young Yoo, et al.. (2019). Oncolytic Herpes Virus Armed with Vasculostatin in Combination with Bevacizumab Abrogates Glioma Invasion via the CCN1 and AKT Signaling Pathways. Molecular Cancer Therapeutics. 18(8). 1418–1429. 27 indexed citations

17.

Shimizu, Toshihiko, Joji Ishida, Kazuhiko Kurozumi, et al.. (2019). δ-Catenin Promotes Bevacizumab-Induced Glioma Invasion. Molecular Cancer Therapeutics. 18(4). 812–822. 15 indexed citations

18.

Otani, Yoshihiro, Tomotsugu Ichikawa, Kazuhiko Kurozumi, et al.. (2017). Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion. Oncogene. 37(6). 777–786. 25 indexed citations

19.

Ishida, Joji, Kazuhiko Kurozumi, Tomotsugu Ichikawa, et al.. (2015). Evaluation of extracellular matrix protein CCN1 as a prognostic factor for glioblastoma. Brain Tumor Pathology. 32(4). 245–252. 11 indexed citations

20.

Otani, Yoshihiro, Kouichiro Tsutsumi, Daisuke Kuwahara, et al.. (2003). Sensitization of head and neck squamous cell carcinoma cells to Fas-mediated apoptosis by the inhibition of Bcl-XL expression. Auris Nasus Larynx. 30. 79–84. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact